SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-020634
Filing Date
2020-10-01
Accepted
2020-10-01 20:22:50
Documents
2
Period of Report
2020-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1359
2 dffn20201001_sec16.htm EX-24 8820
  Complete submission text file 0001437749-20-020634.txt   11891
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DIFFUSION PHARMACEUTICALS INC. 1317 CARLTON AVENUE, SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
Hollingsworth Jane H (Reporting) CIK: 0001297141 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 201217803